The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Abstract
OBJECTIVE: Women with polycystic ovary syndrome (PCOS) are at an increased risk for insulin resistance and hyperlipidemia. Metabolic syndrome is a cluster of risk factors that confers an increased risk for cardiovascular disease. The objectives of this study were to compare the prevalence of metabolic syndrome in women with PCOS and controls and to identify the role of androgens or insulin resistance in the development of metabolic syndrome. METHODS: Women with PCOS (n = 129) and women with regular menses and no hirsutism seen for an annual examination (n = 177) were studied. RESULTS: The age-adjusted prevalence of metabolic syndrome was higher in women with PCOS (47.3%, 95% confidence interval 35.3-56.9%) compared with controls (4.3%, 95% confidence interval 1.9-7.6%, P < .001). Compared by age group, the risk of metabolic syndrome in women with PCOS was higher for all groups (P < .001). There were no significant differences in serum androgen levels between women with PCOS with or without metabolic syndrome. In contrast, all markers of insulin resistance were abnormal in women with PCOS with metabolic syndrome compared with those without metabolic syndrome (P < .001). We found serum triglyceride/high density lipoprotein cholesterol (TG/HDL-C) ratio correlated with insulin resistance in this population (P < .001). Serum TG/HDL-C > 3.2 has a high sensitivity and specificity for the detection of metabolic syndrome in women with PCOS. CONCLUSION: Women with PCOS have a 11-fold increase in the prevalence of metabolic syndrome compared with age-matched controls. The risk of metabolic syndrome is high even at a young age, highlighting the importance of early and regular screening. The TG/HDL-C ratio may serve as a screening tool and needs to be prospectively validated in this group. LEVEL OF EVIDENCE: II-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & Stern, M. P. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,238
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedPolycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Metadata
- Authors
- Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H.
- Venue
- Obstetrics & Gynecology
- Published
- 2005-07
- Volume
- 106
- Issue
- 1
- Pages
- 131-137
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2110925381
- Cited by
- 353
- References
- 29
- FWCI
- 20.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome. https://app.cochat.ai/papers/10.1097/01.aog.0000167408.30893.6b
- The paper
- Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H. (2005). Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome. Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000167408.30893.6b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.